ARCHIVES

FDA Proposes Guidelines For Testing New Anticancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

DO RFAs cut Into R01 Grant Pool? Board Asks

July 2, 1999

Funding Opportunities

April 26, 2002

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012